Montag, 19. Dezember 2016

New Gadget: Thync Mood-Altering Headset Demo

Thync is launching its mood-altering headset today, letting you find a state of calm or boost your energy with controls on your smartphone. Thync’s gadget is more of a module than a headset. It’s small, plastic, and contains a Bluetooth radio for connecting to your phone. You attach it to a disposable adhesive strip, which you apply to your temple and neck.

https://www.youtube.com/watch?v=1KwK5ZGdQAk

Pellentesque venenatis mollis dignissim. Morbi et fringilla dui, at euismod metus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Sed mollis orci nibh, nec dapibus ipsum vestibulum ac. Donec ultricies turpis at eros blandit sollicitudin. Fusce ultrices odio nec pellentesque feugiat.

Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Vestibulum vitae tempus odio, vitae varius velit. Nunc placerat turpis a neque vehicula, ac commodo augue semper. Mauris convallis arcu dui, quis placerat libero venenatis nec. Phasellus efficitur a neque vitae efficitur. Phasellus vel enim leo. Nunc nec vehicula elit, ut lacinia magna.

New Gadget: Thync Mood-Altering Headset Demo

Latest from Apple: Apple Watch Review

The Apple Watch is now on the wrists of members of the general public for the first time, and opinions about its usefulness are flying fast and furious. Here at TechCrunch, we’ve been sharing our thoughts in an ongoing diary, featuring daily entries describing what it’s like to use the Watch as we become more familiar with the new gadget.


https://www.youtube.com/watch?v=LHdVkPrdRYg

Latest from Apple: Apple Watch Review

Slack Integrates With Google Calendar To Add Events To Channels

Slack, the popular office communication tool, will now integrate with Google Calendar, letting events automatically post reminders inside slack channels.

After linking a Google account to Slack, you can choose any calendar and instruct it to post to certain Slack channels. For example, you could have events from your company’s development deadline calendar post reminders to the #dev channel two days before a product deadline.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed at leo in enim sodales dictum sed at lacus. Phasellus mi urna, mattis sed metus non, ullamcorper dictum nibh. Nunc venenatis erat ipsum, dignissim posuere metus accumsan a. Nullam ornare iaculis odio id vestibulum. Praesent blandit turpis iaculis, aliquam magna a, malesuada magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit libero ex, vel sollicitudin lacus suscipit a. Morbi quis mi mollis, ultricies odio et, feugiat nisi. Suspendisse condimentum risus a mauris varius imperdiet ut sed augue. Aliquam ut tortor gravida, ultricies est sed, placerat erat. Cras lacus nisi, convallis nec metus vitae, commodo aliquam neque. Nam viverra ex mi, nec fermentum ante dictum et. Donec eget mi sed neque fermentum feugiat vitae nec enim. Curabitur in mollis turpis. Ut nec pharetra nisi, vitae egestas elit.

Pellentesque venenatis mollis dignissim. Morbi et fringilla dui, at euismod metus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Sed mollis orci nibh, nec dapibus ipsum vestibulum ac. Donec ultricies turpis at eros blandit sollicitudin. Fusce ultrices odio nec pellentesque feugiat. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Vestibulum vitae tempus odio, vitae varius velit. Nunc placerat turpis a neque vehicula, ac commodo augue semper. Mauris convallis arcu dui, quis placerat libero venenatis nec. Phasellus efficitur a neque vitae efficitur. Phasellus vel enim leo. Nunc nec vehicula elit, ut lacinia magna.

Slack Integrates With Google Calendar To Add Events To Channels

YouTube’s New App Plays To Creators

Yes, we love videos of cats falling, but YouTube’s content creator network has blown up over the past few years. There’s some really great content being created by budding superstars.

coughPewDiePiecough.

Today, the company released a new version of its app (Android first, and iOS soon) that helps feed content from those superstars to their fans. The app now has a new subscription tab where you can track all of the latest and greatest from your favorite stars in one place:

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed at leo in enim sodales dictum sed at lacus. Phasellus mi urna, mattis sed metus non, ullamcorper dictum nibh. Nunc venenatis erat ipsum, dignissim posuere metus accumsan a. Nullam ornare iaculis odio id vestibulum. Praesent blandit turpis iaculis, aliquam magna a, malesuada magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit libero ex, vel sollicitudin lacus suscipit a. Morbi quis mi mollis, ultricies odio et, feugiat nisi. Suspendisse condimentum risus a mauris varius imperdiet ut sed augue. Aliquam ut tortor gravida, ultricies est sed, placerat erat. Cras lacus nisi, convallis nec metus vitae, commodo aliquam neque. Nam viverra ex mi, nec fermentum ante dictum et. Donec eget mi sed neque fermentum feugiat vitae nec enim. Curabitur in mollis turpis. Ut nec pharetra nisi, vitae egestas elit.

Pellentesque venenatis mollis dignissim. Morbi et fringilla dui, at euismod metus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Sed mollis orci nibh, nec dapibus ipsum vestibulum ac. Donec ultricies turpis at eros blandit sollicitudin. Fusce ultrices odio nec pellentesque feugiat. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Vestibulum vitae tempus odio, vitae varius velit. Nunc placerat turpis a neque vehicula, ac commodo augue semper. Mauris convallis arcu dui, quis placerat libero venenatis nec. Phasellus efficitur a neque vitae efficitur. Phasellus vel enim leo. Nunc nec vehicula elit, ut lacinia magna.

YouTube’s New App Plays To Creators

Freitag, 16. Dezember 2016

Subscribe to Informatics Agilent, Transcriptic Collaborate on Laboratory Automation

NEW YORK (GenomeWeb) – Agilent Technologies announced today that it will partner with Bay Area lab automation firm Transcriptic to add several Agilent Genomics product lines for mutagenesis and cloning to the protocol library within the Transcriptic robotic cloud laboratory, including QuikChange site-directed mutagenesis kits.

The Transcriptic platform allows for remote, web-based control of life science research, enabling researchers to scale up experiments and reduce human error. The firm is building robotically-driven “workcells” — self-contained boxes filled with automated molecular biology laboratory equipment. Transcriptic has previously partnered with CRISPR design software firm Desktop Genetics to make guide RNA libraries for large-scale screening experiments.

In a statement, Transcriptic COO Yvonne Linney said that Agilent’s QuikChange kits carried a reputation for reliability and ease-of-use, and that the deal will allow researchers to use many mutants to produce large data sets for exploring protein function.

Financial and other terms of the collaboration were not disclosed.

 

Thanks to genomeweb.com

 

 

Subscribe to Informatics Agilent, Transcriptic Collaborate on Laboratory Automation

Mittwoch, 16. November 2016

Keeping up with sample preparation

Located in the heart of the Greater Toronto, Canada, Questron Technologies has been providing high-end sample preparation equipment for metal analysis to analytical laboratories for over 20 years. In the early 1990’s Questron was the first to introduce computer controlled temperature and pressure microwave digestion systems. Continuing our tradition, in 2005 we were the first to introduce the concept of all plastic robotics for laboratories, in the form of automated digestion systems. Our line of products are tailored to specifically provide analytical laboratories with a total solution for sample preparation needs. Our sample prep product range includes:



  • QBlock Wireless Manual Block Digestion system


  • Vulcan Automated Digestion and Work-up Station

  • QLab Pro Microwave Digestion System


  • QPrep Automated Dispensing and Dilution Station


  • QAsh 1800 Microwave Ashing System

Questron is always in touch with users and welcome feedback from industry. In fact this is the key driving factor for new developments and broadening our range of offering. Our group of highly qualified engineers and application specialists make Questron a successful team. We collaborate with renowned universities and industries in proving our new concepts. The result of this approach is our cost-effective QBlock Wireless Digestion system wherein users can control up to eight digestion blocks simultaneously.


As higher throughput becomes more and more of a necessity with stricter regulations being implemented by regulatory agencies, Questron has developed and implemented automated digestion and work-up stations; Vulcan. Combining our QBlock design with a robust all-plastic hood and working robotic arm, users can safely dispense harsh concentrated acids and heat samples. Harmful vapours generated during digestion are easily removed. Stubborn and time consuming work-ups can also be performed directly within Vulcan, no need for unnecessary pipetting and diluting.


Microwave digestion has becomes a staple in the field of sample prep for many labs across the world. Questron strives to provide customers with the most reliable, efficient and safest means for this process, through our line of QLab Pro microwave digestion systems.


Questron’s vast distribution network has allowed labs worldwide to experience and incorporate our systems into their daily workflow routines, saving them time and money. Most importantly our products provide a safe alternative to traditionally harsh work environments, being recently internationally recognised as a winner for lab safety with our Vulcan line of systems.


Adaptability to meet industry demand is our moto when it comes to customer satisfaction. We provide customisation for all our products in order to accommodate the special needs of customers and provide unique solutions. Custom size blocks to accommodate odd vial sizes and lab automation for difficult situations is something our customers love about us.


We would like to hear from you. You can reach us by visiting our website, or contact us by phone at 1-844-363-1223 or email.


https://youtu.be/7-L2KuEOP8s


 


See more at: https://www.labmate-online.com



Keeping up with sample preparation

Donnerstag, 3. November 2016

From Excel spreadsheets to automation and robots: One biotech company"s journey of IT discovery

Horizon Discovery has just embarked on a massive overhaul of the IT estate underpinning its commercial operations. Now, it plans to do the same for the science side of its business.



labpcr
Robots could be helping out Horizon Discovery’s scientists with their lab work in future.Image: Getty Images/iStockphoto


It’s no secret that organisations across the world are generating more data than ever before. But for those in the genomics field, the data challenge is not only bigger than ever, it may be bigger than anyone else’s: it’s thought that in the coming years, the field will generate more data than any other industry.


For Juergen Harter, not only is his organisation characterised by huge volumes of data, until recently it was also characterised by Excel spreadsheets used to store vital business data.


Harter is the VP of information systems at Horizon Discovery, a biotech company based in the English city of Cambridge, which also has sites in the US and in the Austrian capital of Vienna. The company provides services from gene editing to modelling, to support the world’s largest pharmaceutical companies in drug development.


As well as providing IT services for scientists working on cell biology, Harter also has to support a traditional salesforce and other support staff that were, until recently, using Excel as a repository for customer data.


Following the purchase of several biotech companies between 2014 and 2015, the company found itself not only having to integrate those acquisitions, but also the legacy business software systems that each brought with them. As a result, the company embarked on a program of consolidating its CRM, ERP, and productivity platforms.


All of the different Microsoft Exchange systems and email domains were consolidated, the Excel spreadsheets were replaced by Dynamics, and Skype for Business was brought in for unified comms.


“We decided to go with a Microsoft E3 site-wide license and then push every user into Office 365 because that allows everybody to be on one email system and have all the Office applications running in one unified way. That more or less allowed us to put everything together to form the Horizon Group,” Harter said.


While the Dynamics CRM is in the cloud, the AX ERP remains on-premises, though over time the latter is likely to be moved to a hosted option as well.





If you’ve got some programming or scripting experience, this course will teach you the techniques used by real data scientists in the tech industry – and prepare you for a move into this hot career path. This comprehensive course includes 68 lectures spanning almost 9 hours of video, and most topics include hands-on Python code examples you can use for reference and for practice.





“If this was day one on the two-year AX deployment, I might go more toward that cloud release, but two years ago, we decided on-prem was the right route for that part. Last year, we started the CRM deployment. It took about a year and we had to unify five different old legacy CRM systems for that, but I thought it was mature enough for the cloud,” Harter said.


While the commercial side of the business is now largely standardised on Microsoft underpinnings, the scientific side is a different story: though the former may have been fragmented across different versions of Redmond’s products, the latter is fragmented across tens of platforms, both homegrown and bought-in, proprietary and open source, cloud and on-premises.


According to an analysis carried out by Harter’s team a couple of years ago, there were between 100 and 200 separate software platforms used by researchers, from something used by what the IT chief describes as “just 10 scientists running locally on some desktops”, to more complex gene-editing platforms running off AWS.


The situation is unlikely to remain that way for long: Harter expects a second software unification push on the scientific side of the business to be on the agenda soon.


Looking at the software fragmentation on the commercial side of the business, “the answer there was easy — we knew we had to consolidate, we knew the benefits we would get because the entire salesforce will be able to have the whole dialogue with the client stored in the CRM, be able to access it remotely, you name it — it was easy and clear the path you take there. On the scientific side, things are less clear because you can go in so many different directions depending on the business model you’re driving and a lot of these applications produce an awful lot of data,” said Harter.


When it comes to genomics and biotech, an awful lot of data means volumes that most companies may find unimaginable, or at least unmanageable.


“Over the last couple of years, we have got more and more databases showing up and generally we understand the knowledge-mapping much better, and where data comes from and metadata on it. The volume and has grown and grown. That’s in line with all the trends you’d see elsewhere, but with biotech and genomics, it’s even more exacerbated. The rate of data growth is far, far higher,” Harter said.


Taming that data so clients and in-house researchers can make the most of it is also a priority for Harter, and Horizon Discovery’s central IT teams will be focused on improved advanced enterprise search, to help customers find the data they need when they need it, and researchers to find patterns within all the information they’ve gathered.



“If people are searching for cell lines on the Horizon website and, say, they work on Alzheimer’s and need to know which genes are implicated, we use bioinformatics underneath — we are in the process of utilising ontologies like disease ontologies to help optimise the search query so we deliver the right genes and guide their search efforts far better. We’re trying to exploit our wealth of scientific data in the databases around Horizon to learn from what we already know about the cell,” Harter added.


The joint challenge of both a growing volume of data and an increasing need to be able to query it effectively mean that Horizon Discovery’s team are looking at new ways to store and share its datasets.


In tandem with working out how to scale its on premise storage, Horizon Discovery’s infrastructure staff are looking at what data can be moved to the cloud, and how data stored there can be more easily shared with clients. For the move “from cloud to cloud or via APIs upload or portals, we’ve looked at all those different technologies. It’s grown a long way from someone sends an attachment around or whatever,” according to Harter.


Further off, Horizon Discovery is looking at what more advanced technologies it could bring to bear in the fight against cancer and the drive towards precision medicine. The company is already looking towards artificial intelligence and machine learning, as well as robotics.


“On the scientific side, we are keen to introduce far more automation, and ultimately more down the road robotics for lab automation. […] There will be more software needed to handle any data that comes off machines and robots down the line. That area is growing and growing,” Harter said.


 


Source: http://www.zdnet.com/



From Excel spreadsheets to automation and robots: One biotech company"s journey of IT discovery

Donnerstag, 13. Oktober 2016

Basel Life Science Week 2016: A “flurry of scientific intellect”

The annual Basel Life Science Week (BLSW) in Switzerland was host to many organisations and individuals all interested in various sectors of science, ranging from precession medicine to synthetic biology, but a common theme was apparent throughout: innovation. Benchmark achievements and breakthroughs were defined by the various attendees in different terms, but how these advancements are executed was a recurring theme. It was clear from the workshops and exhibitions that accelerating science to keep up with the future pace of R&D was paramount to all.


 


The question that I see most, is how vendors like IDBS would help to manage R&D and transform lab operations; however, the question that needs to be answered first is what are you trying to do with your business and what sort of business models are relevant to you? There is a great desire to employ the latest technologies, in order to enhance collaboration with other scientists, but the question still remains: is technology the ‘silver bullet’?


I was lucky enough to be invited to speak, and my presentation focused appropriately on the ‘Lab of the Future’ (LotF) and the role that technology would play within it.  To begin with, LotF is not about finding a use for new technology. It is about driving best practices in data management and transforming the laboratory along with the rapid pace of change, all while embracing innovation and the needs of the End User.


Today’s LotF themes have different connotations to different business units, making it impossible to place a universal definition of what that lab might look like.  Every organisation will have different business drivers, including the existing technological infrastructure, processes employed and the scientists themselves, which should all be considered when determining your ‘Lab of the Future’ strategy.


We see three trending strategies common to all our customers in this regard: Automation, Collaboration and Ergonomics.


 


It is amazing to see the impact the consumer market, Internet of Things and advances in smart technology have in shaping our expectations around improving laboratory operations.


Automation


This usually leads to automation and looking at your processes, which automation by definition is meant to improve.  One thing that strikes me, is how often people focus on automating existing practises – what I call ‘automating the past’ – rather than starting with a bottom-up review of current processes.


Start with questions; are current processes holding you back, are you leveraging informatics platforms to streamline processes? To properly apply the benefits of automation requires a deeper understanding of business processes, a review of the interaction between groups and a better picture of how the data flows and is reported in order to eliminate manual steps.


This practice of determining the ‘As-is’ and ‘To-be’ processes help to identify and rank opportunities for improvement as well as quantify project ROI is beneficial to all.


Collaboration


Collaboration and outsourcing is nothing new in the life sciences field, and underpins the business drivers listed above.


Operational and infrastructure costs can be reduced, but for some, it is about efficiency and increasing the speed at which new developments can be brought to market.  Innovation as we all know is fostered through increased collaboration, but this usually comes with its own set of challenges.


How do you link data to data and people to people across the firewall?


You want to reap the benefits of automation without taking a step backwards, but outside the firewall means extra logistics and integration challenges – particularly the sharing of secure data in a timely manner, protection of IP and ensuring quality of data and integration of systems. That said, paper lab processes are not risk free.


Notebooks can be lost, stolen or even illegible. In order to maximise the benefits of collaboration, you need a balance of openness and protection that allows for conversations to happen in real time. It is important to find a solution that does this and introduces elements from the consumer world and social media norms such as comments, activity feeds and ways to have conversation in real time – and I do not mean email!


Ergonomics


Ergonomics in the lab environment is, again, a subject that has been widely discussed. While this has traditionally focused on the physical set up of the lab, the proliferation of mobile devices has had a significant impact on the work of scientists in the lab. But mobile devices in and of themselves are not necessarily the answer: the key is to give access to the interface best suited to the job.


Science is developed by scientists and technology can enable these discoveries from breakthrough to implementation. Ultimately, vendors need to provide the technology that allows customers to leverage their capabilities to manage their LotF strategy.


BLSW was a flurry of scientific intellect and I’m looking forward to seeing what developments, ideas and breakthroughs will feature next year.


 


J.T. Kaminski has been with IDBS since 2008 leading the U.S. North East’s services teams until 2015, where he transitioned to his current role asDirector of Technology Services EMEA, providing transformational business services through successful project implementations and change management.


 


Source: http://www.drugtargetreview.com/



Basel Life Science Week 2016: A “flurry of scientific intellect”

Montag, 26. September 2016

Lab Automation & Robotics, 8-9 November 2016, Berlin, Germany

Following last year’s successful event in Hannover, we move to Berlin for 2016.  SELECTBIO’s 6th annual Lab Automation & Robotics is an industry forum where lab professionals and engineers can share best practice and innovations in this fast moving field.


 


Agenda Topics:


  • Applications of Automation and Robotics in:
    • Analytical Laboratories

    • Biobanking & Biorepositories

    • Genomics Research


  • Case Studies

  • Control Software and Standards

  • Novel Hardware and Components

You can present your research on a poster while attending the meeting. Poster submission deadline:14 October 2016.


Visit the website for up-to-date information, including agenda, and our 3 for 2 offer on registrations!


http://ow.ly/iT3P301wEca


 


Keynote Speakers





Crook

Malcolm Crook

Director, Peak Analysis & Automation Ltd



Graber

Niklaus Graber

President , SiLA



Lab Automation & Robotics, 8-9 November 2016, Berlin, Germany

Mittwoch, 21. September 2016

This startup is selling $1 million plates of made-to-order, custom-built DNA to companies like Microsoft

In San Francisco’s Mission Bay neighborhood, a 20-minute streetcar ride away from Google’s city offices, lies hidden a DNA factory.


That’s not an embellishment: Twist Bioscience, a venture-funded startup with investors including Russian billionaire Yuri Milner and Dr. Boris Nikolic, science advisor to Bill Gates, is writing millions of dollars worth of made-to-order synthesized DNA to silicon slabs, just a few inches in surface area.


The custom DNA market has been around for decades. But now, it’s poised to explode, as drugmakers and biology labs across the world turn to bespoke DNA samples to explore gene therapy and create new vaccines.


Now, there’s even more demand for custom DNA than ever before, as companies like Microsoft start to explore the possibilities of using DNA as a kind of super-intense hard drive to store lots of data even in the event of global apocalypse. In fact, Microsoft bought 10,000 strands of custom DNA from Twist earlier in 2016.


twist foundersTwist Bioscience founders, left to right: Emily Leproust, Bill Banyai, Bill Peck


Twist CEO Emily Leproust, PhD, is very careful to say that while Twist didn’t invent the process of writing custom DNA, they’re applying a Silicon Valley mindset to making the process cheaper, easier, and more flexible than ever before.


“We are an engineering company, not a chemistry company,” saysLeproust.


(Oh, and in case you’re concerned, the DNA printed by Twist isn’t really “alive” by any measure. It’s just immensely tiny protein molecules.)


DNA machine


The key to the whole affair lies in a machine that’s so proprietary and important to Twist, I wasn’t allowed to take pictures and the company doesn’t publish any on the web.


Laboratories have been using machines synthesizing custom DNA since the early 1970’s. But the process has historically been time-consuming, slow, and prone to errors: It’s hard for say, Microsoft, to try a new experiment when you need to wait “weeks and weeks and maybe even months” for your custom DNA to arrive, Leproust says.


Twist’s top-secret solution automates much of the process with a machine that looks a little like the the inkjet printer you may have at your office. Little “ink” tanks hold the raw DNA bases that they can put into sequence, per the customers’ order.


twist macro06 cZoomed into Twist Bioscience’s 10,000-well silicon plate. Each well has a 600 um diameter dimension.Zoomed into Twist Bioscience’s 10,000-well silicon plate. Each well has a 600 um diameter dimension.


As the nozzle passes over a wafer of silicon, the same heat-tolerant mineral used for computer processors, it deposits 10,000 “blisters” of DNA bases every 21 minutes or so. Once the DNA is written to the wafer, it goes upstairs to a different laboratory for final processing and preservation, turning those “blisters” into deeper and more resilient “wells,” so it can be shipped out.


It’s like Kinko’s, but each print costs $1 million and might go to better mankind. With each wafer so valuable to the company, accuracy becomes key: You don’t want to put “the million dollars at risk,” as Leproust says.


Before each pass of the machine, a camera on the printer’s nozzle actually lines up with little crosshair targets on the silicon. When you’re dealing with microscopic bits of DNA, even getting it just a little bit off-kilter can result in the whole wafer having to be tossed out.


Then, after final processing, it’s taken off the silicon wafer and shipped out to customers in vials.


The business case


Okay, so each DNA-laden wafer sells for $1 million. But who’s buying?


Lots of biology labs have need for custom DNA, for everything from testing new vaccines to using gene therapy to develop new drugs.


But since custom DNA synthesis has historically been so slow and so pricey, labs have been forced by budgetary restrictions to go to other, cheaper alternatives, including cloning, where you give up the ability to custom-design your sample by making a literal genetic copy of your existing samples.


dogclonesThese puppies were cloned from each other.Getty Images


“They have more ideas than they had money,” Leproust says.


While Twist is charging customers a lot, it’s still as much as one-third the price as custom DNA has cost historically, Leproust says. And Twist’s turnaround time for delivering the DNA is days, not weeks. Customers can do science, tweak their parameters, and have a new sample to continue research all within a week.


Right place, right time


It’s a case of being in the right place at the right time, too. The science of genetic research is progressing nicely, making for a nice and growing market for Twist’s products. But the tech giants, notably Microsoft, are starting to experiment with using DNA for computer storage.


Big businesses, banks, and hospitals all have a habit of storing important archival data on old-fashioned magnetic tape storage, basically big cassette tapes. But those tapes tend to wear out after 30 years, meaning decades of data can be lost.


loading 20machineA Twist scientist prepares to load the silicon plate into the custom DNA writing machine.Twist Bioscience


DNA, though, has a ton of potential. Unlike magnetic tape, DNA can stay totally intact and readable for as long as 10,000 years, in the right situation. Once the science gets far enough, DNA can store a lot of data, too: You can fit “the whole internet in a shoebox” one day, Leproust says.


Ultimately Microsoft Research estimates that one cubic millimeter of DNA can eventually store one exabyte, or one billion gigabytes of data. But the science is handicapped by the fact that it’s tough to actually store that much data.


And while technology trends may come and go, there’s going to be a need and capability to “read” human DNA for as long as there are humans, meaning it’s way more reliable.


In all cases, the market for custom genes is around $1 billion and $15 billion for DNA storage, Leproust says, and both markets are only growing as the world wakes up to its potential. And if everybody is going to want DNA, Leproust sees Twist as playing an important role in getting it to them.


“I want to be the one to make the DNA,” Leproust says.



This startup is selling $1 million plates of made-to-order, custom-built DNA to companies like Microsoft

Mittwoch, 14. September 2016

The revolutionary Lateral Flow Device Assembly

The revolutionary Lateral Flow Device Assembly solution combines intelligent automation and modularity on a desktop scale. It provides manufacturers flexible rapid test production capacity within a desktop footprint.


The solution is easily adaptable and can assemble different rapid tests with minimal product specific adjustments. Machine vision guidance and quality control throughout the entire system ensure a consistent high quality assembled device. The LFDA solution is built on Ginolis’s modular Xanthia robotic platform. The modular design provides speed, accuracy and precision, as well as flexibility for the future.


The Lateral Flow Test production line includes a bulk feeder, rotating disc and Scara robots for the infeed of cassettes or housings, an intelligent conveyor for material transfer, vision guided strip cutting and placement, electrically functioning press unit and a final comprehensive quality control check.

For more information about Ginolis’ Lateral Flow Device Assembly solutions visit http://ginolis.com/lateral_flow_devic… or contact info@ginolis.com


Modules and Applications: bulk feeders, intelligent conveyor, Scara robots, strip infeed with single card, car magazine or reel modules, press unit with force and height parameters, integrated machine vision quality control and reject outfeed


 


https://www.youtube.com/watch?v=4BHBRRhf1fw&feature=youtu.be



The revolutionary Lateral Flow Device Assembly

Mittwoch, 7. September 2016

New low-cost opportunities for science

Competition for funding in science is stiff and tends to get stiffer as the number of PhD graduates explodes, together with reduction in government research funding when crises strike, for example. While crowdfunding is a way to overcome this problem, even this alternative is likely to become very competitive. Scientists need to find low-cost alternatives in order to continue making good science. Fortunately, prospects have never been better in this field. Here I examine two new technologies that can help scientists to conduct their research at much lower cost than inside the traditional pathway. They are open-source hardware and scripting.

Open-source hardware

Open-source hardware consists in machines that have their blueprints freely available. Therefore, they can be reproduced by anyone with the means to build them. Nowadays, this has been more accessible than ever. Microcontrollers, like Arduino and Raspberry pi, (which are themselves open-source, by the way) allow people with elementary knowledge on electronics to build devices. At the same time, 3D printers allow low-cost fabrication of customized parts. Joining microcontrollers and customized 3D-printed parts, production costs can be really low. As a consequence, there is a plethora of devices which have their blueprints openly available on the internet, and that can be built at a very low cost. Many of such devices are specifically designed for use in the laboratory, like syringe pumps and spectrophotometers. Others not necessarily, like robotic arms. In any case, they can all be used in laboratory contexts.

The main advantage of using open-source hardware compared to commercial instruments is the cost: open-source hardware can cost less than 10% of similar commercial instruments while performing exactly the same task. Thus, for some cases even crowd funding may not be necessary: a few hundreds of dollars can be enough to fund a research project. It must be understood that the lower cost of open-source devices does not mean that their quality is inferior to their commercial counterparts. Especially in science, devices are vastly overpriced. This is not necessarily greed: the market scale in science is small when compared to that of the general public, and thus manufacturers need to charge high prices or their business collapses. This means that a device with the same technology of a common home printer, like many autosamplers, for example, can cost a hundred times or more than the printer. What happens many times is that some commercial devices can only be used together with others from the same manufacturer by design. In such case, scientists are hostage of the situation and need to purchase the expensive accessory even knowing that more affordable alternatives exist, like those based on open-source hardware. This brings us to the second technology that helps scientists to save money in the laboratory: scripting.

Scripting

Scripting is a kind of programming. Without delving into technical details, scripting can be seen as an easy variety of programming, easy enough to be promptly accessible to people without time to devote to learn complex subjects, which is the case of most laboratory technicians or scientists. The main way by which scripting can help scientists save money in the laboratory is by enabling compatibility between devices from different manufactures, regardless of their originally designed purpose. Scripting allows that because it acts at the software, and not hardware, level. From a very simplistic angle, scripting is a kind of sophisticated scheduling: the tasks performed by a given instrument can be synchronized with those performed by another, provided that both are being controlled by a single computer (or group of connected computers). Scripting power resides in its simplicity: with scripting, it is possible to control mouse clicks and keyboard inputs. Therefore, scripting effectively substitute a person controlling the computer, and repeat her actions over and over.

The problem of lack of compatibility between scientific instruments is an old one. The response of the industry has been the proposal of standardization of scientific instruments, but this has never come true. The main reason for the failure of standardization is that, differently from scripting, it acts mostly at the hardware level by modifying the instruments themselves. Beyond being a complex task, which involves professionals from diverse backgrounds, standardization costs money both for manufacturers and for users. In contrast, scripting is entirely free (AutoIt, for example, is a free scripting language that allows control of mouse clicks and keyboard shortcuts) and easily accessible. In addition to that, standardization necessarily creates a “club”, where insiders have the control of who can enter or not. This is a grave obstacle that hampers the adoption of the amazing devices developed in the explosion of creativity enabled by recent developments in open-source hardware, for example.

Democratization of science

These are exciting times for scientists. Crowd funding enables anyone with a good idea to make it real. Open-source hardware lowers the cost of devices by more than 90% of what they cost just a few years ago. Scripting makes these devices work together, and also together with commercial devices. More than ever, stunning technological advances can be a part of scientific discovery even in the most modest laboratories. These are times of true democratization of science.

New low-cost opportunities for science

Donnerstag, 25. August 2016

GHP (Global Health & Pharma) Magazine Gives GeoMetrick Enterprises 2016 International Life Sciences Award

GeoMetrick Enterprises has been included in the GHP (Global Health and Pharma) Magazine 2016 International Life Sciences Awards naming this Ann Arbor, Michigan-based business “Best Laboratory Informatics Solutions Company – USA.”

GHP Magazine states that, as “[recognition of] the exceptional work of firms in this industry, the 2016 International Life Sciences Awards are a snapshot of the best this market has to offer.”

About GeoMetrick Enterprises:

GeoMetrick Enterprises provides laboratory software services for systems such as LIMS, ELN and LES. These services range from working with customers to select the right type of and brand of software, as well as implementations services such as configuration, programming and documentation. GeoMetrick Enteprises is a Thermo Fisher Scientific Informatics partner, works with customers ranging from the Fortune 50 companies to startups to software vendors such as iVention, and within many industries including but not limited to genomics, pharmaceuticals and consumer goods, both for regulated and non-regulated applications, for customers both in the United States and out. GeoMetrick Enterprises is the home of the internationally-known industry blog Out on a LIMS®: The Blog for People Who Risk Life and LIMS(TM) on a Daily Basis.

GeoMetrick Enterprises also provide laboratory services such as SOP planning and writing, fermentation scale-up assistance, method development, and distilling and contamination consulting. GeoMetrick Enterprises is also the home of the industry blog HPLC’N You

About the International Life Sciences Awards, according to GHP Magazine:

“The 2016 International Life Sciences Awards are our way of celebrating what is undeniably a truly unique and critical field. We are devoted to giving this captivating and fundamental industry the recognition it truly deserves.

As with all of our awards, these titles are given purely on merit, and we do not take into account company size, geography or reputation. Instead we are focusing on firms, departments and individuals who are dedicated to producing innovative new ideas which will drive the industry forward. Nominations have been passed on to our dedicated awards team, who will diligently research each firm to ensure that all our winners can be assured that their award is truly deserved.”

GHP (Global Health & Pharma) Magazine Gives GeoMetrick Enterprises 2016 International Life Sciences Award

Freitag, 19. August 2016

Quick reminder: Basel Life Science Week starting soon!

Leading Figures from Drug Discovery and Life Sciences to Gather for

Basel Life Science Week – MipTec 2016 in Basel


BLSW – MipTec is Europe’s largest conference on drug discovery and draws 3,000 participants from over 50 countries each year. The event takes place at the Congress Center Basel (Switzerland) from 19–23 September 2016 and offers a high-calibre program.


This autumn, the scientific elite in pharmaceutical research will again come together in Basel. The event has grown from its origins as a specialist conference for laboratory automation into a leading global conference in the life sciences sector. By offering a broad and diverse but also deeply scientific conference program, the conference plays a vital role in helping pharma and biotech scientists successfully attack the significant challenges in modern-day drug research and development work.


The 2016 science programme will have multiple streams with leading science experts covering the following topics:


  • Aging and Drug Discovery

  • Basel Agenda – Digital Health

  • Basel Microfluidics

  • Best Practices in Clinical and Research Genomics and Data Warehousing

  • Status and Future of (Standardized) Research Data Warehouses

  • Best practices in genomics data analysis for clinical and research applications

  • Best practices in data storage integrity and security

  • Current challenges in protein science: from fundamental research to drug development

  • Jumpstarting Innovation – Early stage investing, start-up-incubation and how to enable the future generation of biotech innovators

  • Infectious Diseases

  • Medicinal Chemistry and Drug Discovery

  • Molecular Diagnostics brought by NTN Swiss Biotech

  • Peptide Therapeutics

  • Stem Cells in Biomedicine

  • Synergy

  • Synthetic Biology

 


Keynote Lectures:


  • Richard Mason – Head of Johnson & Johnson Innovation

  • Susan Gasser – Director of the Friedrich Miescher Institute for Biomedical

  • Shai Silberberg – Director of Research Quality Enhancement

    National Institute of Neurological Disorders and Stroke, NIH

Workshops:


  • Genome Editing: Strategies for Engineering a Model Cell Line – hosted by Merck

  • Strategic recalibration: What’s next for me? – hosted by Grass & Partner AG

  • Be on brand – in your resume, during an interview, in daily life  – hosted by Grass & Partner AG

  • Career workshops with Peggy McKee

Industry Exhibition


Parallel to the scientific program, the MipTec exhibition will take place in Hall 4.1 in the Congress Center Basel. More than 60 companies will showcase their products and services in the exhibition area.


Registration


The registration for Basel Life Science Week is free of charge. Please register here: www.basellife.org


 


 



Quick reminder: Basel Life Science Week starting soon!

Donnerstag, 4. August 2016

Unchained Labs makes lab automation a no-brainer with freeslate and freeslate jr.




Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, launched their freeslate and freeslate jr. systems for biologics formulation, small molecule preformulation and process chemistry today. These platforms automate laboratory workflows that currently eat up tons of time for individual researchers.


Freeslate takes on the hard stuff in the lab and gives scientists automated, high-throughput, end-to-end workflow solutions. Researchers can churn through more screens, conditions and structures earlier in the development process and get to their most stable biologic, the best druggable form of their API or primo reaction conditions way faster. Freeslate also lets them run hundreds of experiments in parallel and do it with way less material, so rapid and deep exploration of their formulation space or chemical formula is totally doable.







Freeslate jr. lets researchers walk up, set up their run and walk away. It automates the hands-on, back and forth tasks scientists do one by one at the bench now, and turns all of it into one entirely routine, high-throughput process. Scientists can crank through more samples in a single day and get everything done the same, consistent way every time.


“Today, freeslate and freeslate jr. systems are solving major workflow problems all over the place,” said Taegen Clary, VP of Marketing at Unchained Labs. “Scientists dealing with bottlenecks in their biologics formulation, small molecule preformulation or chemistry workflows really need to check out the freeslate systems – odds are we have a solution that will break through them.”


About Unchained Labs


Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it. We’re located in Pleasanton, CA and can be found online at www.unchainedlabs.com.


Contact:


Taegen Clary

VP of Marketing, Unchained Labs
taegen.clary@unchainedlabs.com

925.587.9806



SOURCE Unchained Labs




Unchained Labs makes lab automation a no-brainer with freeslate and freeslate jr.

Montag, 25. Juli 2016

Quick Delivery of Piezo Nanopositioning Systems for Photonics, Microscopy, Semiconductor, Automation Markets

PI launches new accelerated delivery of high quality nanopositioning core components.


As a worldwide leader in nanopositioning and precision motion control solutions, PI continues to innovate, adding advanced and affordable nanopositioning controllers to the mix of piezo systems on the quick delivery list. These systems are geared toward OEM production automation, metrology systems, scientific research, and lab automation applications.

The on-hand availability, coupled with rapid shipment, enables quick integration without long lead and planning times.

Piezo motion is used when an application requires any combination of these parameters: fast response, high precision, high force, long life, maintenance and lubricants free, compact dimensions, non-magnetic, UHV compatible.

Learn more about the systems currently available here.

Read Piezo Motion Tutorial

 

“PI’s innate expertise in producing the highest quality piezo systems with short lead times will continue to lead the market in the future.”

Dr. Mathias Bach, Head of Business Development and Product Management Product Division Piezo-Systems.


 

PI is a leading manufacturer of piezo ceramic components, precision motion control equipment, piezo motors, air bearing stages and hexapod parallel-kinematics for semiconductor applications, photonics, bio-nano-technology and medical engineering. PI has been developing and manufacturing standard & custom precision products with piezoceramic and electromagnetic drives for 4 decades. The company has been ISO 9001 certified since 1994 and provides innovative, high-quality solutions for OEM and research. PI is present worldwide with twelve subsidiaries, R&D / engineering on 3 continents and total staff of 850+.

Credit: http://www.azonano.com/

Quick Delivery of Piezo Nanopositioning Systems for Photonics, Microscopy, Semiconductor, Automation Markets

Freitag, 8. Juli 2016

Basel Life Science Week is rolling out again

Leading Figures from Drug Discovery and Life Sciences to Gather for

Basel Life Science Week – Mip Tec 2016 in Basel


BLSW – MipTec is Europe’s largest conference on drug discovery and draws 3,000 participants from over 50 countries each year. The event takes place at the Congress Center Basel (Switzerland) from 19–23 September 2016 and offers a high-calibre program.


This autumn, the scientific elite in pharmaceutical research will again come together in Basel. The event has grown from its origins as a specialist conference for laboratory automation into a leading global conference in the life sciences sector. By offering a broad and diverse but also deeply scientific conference program, the conference plays a vital role in helping pharma and biotech scientists successfully attack the significant challenges in modern-day drug research and development work.


The 2016 science programme will have multiple streams with leading science experts covering advances in aging, cell signaling, medicinal chemistry, synergy of combination drug therapies, digital health, best practices in clinical and research genomics and data warehousing, peptide therapies, protein sciences, infectious diseases, molecular diagnostics and synthetic biology.


Parallel to the scientific program, the MipTec exhibition will take place in Hall 4.1 in the Congress Center Basel.


The registration for Basel Life Science Week is free of charge. Please register here: www.basellife.org


 


 



Basel Life Science Week is rolling out again

Sonntag, 19. Juni 2016

Google Deep Dream an Laboratory Robots

It was boooring, so I startet a little experiment. Using Google Deep Dream, I picked some laboratory robots to be transformed into a neuronal network generated image. Every source image went thru 6 “dreaming cycles”, using lots of computing power to reach the so-called LEVEL1. I think this is something nobody has ever done before, and I am interested in your comments and what you think is the best image. By the way, I love neuronal networks 😀 (I hope I can count me in as well)..


dream efa4581549dream b0dd16d8c4dream cf82e56ece


 


 



Google Deep Dream an Laboratory Robots

Freitag, 17. Juni 2016

The need for speed

Drug discovery scientists are continuously in search of new technologies and methodologies that will deliver more information, faster screening and greater insight. Sergei Dikler discusses the role that mass spectrometry and the latest MALDI-TOF systems have in the future of drug discovery. Developments in screening and detection techniques alongside advances in automation and computer technologies have paved the way for the emergence of High-Throughput Screening (HTS), which allows pharmaceutical researchers to quickly and cost-effectively assess large numbers of compounds for suitability to be advanced through the drug discovery and development process. While factors such as target selection and assay design remain within the researcher’s control, the primary consideration for successful high-throughput screening remains the selection of the appropriate technology and method.


Important points to take into account when considering a new HTS technology include:

• How many of your target types can be assessed?

• Do the readouts provide more relevant information than your current assays?

• Does it deliver appropriate sensitivity?

• Can you work at relevant concentrations?

• Does the complexity of detection steps required limit ease of assay development?

• Does it deliver appropriate sample throughput speed?

• Can you identify and control artifacts or potential interferences?

• Is the implementation cost prohibitive?

• What level of training/ skill is required to use the instrument effectively?

• Can it be adopted, and deployed, throughout the organisation?


Over the past decade, label-free detection methods based on mass spectrometry (MS) have expanded into HTS applications to replace traditional biochemical assays, which required chemical derivatisation of substrates using labelling reagents necessary for detection. Early MS techniques – including multiplexed liquid chromatography (LC)-MS technology – provided more information on samples than the single point, single analyte traditional biochemical assays. But this additional data came at a cost. With cycle times of up to 30 seconds per sample using (LC)-MS technology, and around 10 seconds per sample when using Solid Phase Extraction (SPE) techniques, mass spectrometry was still considered relatively slow for routine HTS. Most recently, MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry) has been re-examined and has emerged as a compelling alternative for high-throughput MS detection in the pharmaceutical industry. The latest MALDI-TOF systems offer a number of benefits in comparison to the LC-MS and SPE-MS alternatives (Table below).
















ConsiderationBenefit of MALDI-TOF
Detection capabilityTrue label-free detection of native substrates and products in functional biochemical assays
ThroughputFast MS-based screening with cycle times of less than 1s per sample
VolumeReduced sample volume (reaction volume as low as 1 uL, spotting volume as low as 25 nL)
WasteSignificantly reduced solvent use and subsequent chemical waste
Method developmentStraightforward method development, with no sample pre-treatment required
Ease of useRobust automation options

So, how do these benefits translate into real-world performance in the lab? As an example, let’s take a screening of 200,000 compounds, comparing MALDI-TOF with a x4 LS-MS multiplex assay and SPE-MS alternatives. With an assumed cycle time of 20 seconds per sample from a x4 multiplex assay, it would take 54 days to complete the screen. The SPE-MS method, with a cycle time of 7.5 seconds per sample, would complete the screen in 20 days. A MALDI-TOF protocol, with a 1 second cycle time per sample, would screen the 200,000 compounds in just 3 days. The latest MADLI-TOF systems meet the necessary criteria for a new HTS methodology across pharmaceutical applications. From a practical perspective, the technology delivers on multiple counts – enabling straightforward method development and providing monitoring of relevant products at appropriate levels of sensitivity. Notably, assays are also lower in cost when compared with alternative LC-MS and SPE-MS methods.


Table 1


Table 1: Throughput calculation: analysis time per sample/samples per day, based on average of three measurements per target using different acquisition parameters.


Most importantly of all, with the new levels of speed achieved in today’s instruments, MALDI-TOF now enables screening of the very largest libraries of compounds, permitting true acceleration of the early stages of the drug discovery and development process.


A new benchmark


Recent work has established a new performance benchmark for an optimised, fully automated high-throughput screening system based on MALDI-TOF instrument.


Method

A fully automated MALDI PharmaPulse system (Bruker Daltonics) was used to process the plates containing the quenched assay reaction mixture, alpha-cyano-4-hydroxycinnamic acid matrix solution and wash solvent. The system included an ACell robotic arm (HighRes Biosolutions), PicoServe plate hotel (HighRes Biosolutions), LidValet delidder (HighRes Biosolutions), and mosquito HTS liquid handler (TTP Labtech).

The system transferred, in 1536 well format, a sample of reaction mixture and matrix onto MALDI targets comprised of an adapter and polished steel insert with 1.0 mm thickness.

After drying, the samples were analyzed on an autoflex speed MALDI-TOF mass spectrometer (Bruker Daltonics Inc.) equipped with a 2 kHz solid state laser and Acquiris 4 GHz digitizer. The automated runs were set up with 100-1000 laser shots per spectrum to assess the overall speed of analysis.

The run time per target was averaged from three measurements and used to calculate the analysis time per sample and the throughput per day.


Results

The analysis time of MALDI high-throughput screening runs was consistently less than 1 second per sample, with best performance at a significantly reduced to 0.54 seconds per sample (Table 2). This equates to an ability to analyse more than 121,000 samples per day.

Number of laser shots had the biggest effect on the analysis time per sample and thus the throughput per day (Table 1). Decreasing the number of laser shots from 1000 to 100 reduced the analysis time per sample from 0.97 seconds to 0.54 seconds. Consequently, throughput increased from 75,000 samples to 121,000 samples per day taking into account the target loading/unloading time, which was calculated as

2 minutes 9 seconds on average.

Expanding the detection range from 500 Da wide window (2700-3200 Da) to 5000 Da wide window (700-5700 Da) increased the run time per target for the 200 laser shot automated run by only 47 seconds, from 14 minutes 59 seconds to 15 minutes 46 seconds (Table 1). Although the detection range has some impact on throughput, the effect on speed is much less significant than the number of laser shots.

As expected, the laser repetition rate had a significant effect on the analysis time per sample with identical time per sample (0.97 seconds ) for the automated run acquired at 2 kHz and 1000 laser shots and the run acquired at 1 kHz and 500 laser shots (Table 1).


Conclusion

MALDI PharmaPulse achieved speeds of 0.5-1.0 seconds per sample, which is 10-100

times faster than multiplexed LC-MS or SPE-MS techniques.

MALDI-HTS throughput of more than 100,000 samples per day is equivalent to the rate offered by traditional fluorescence based screening methods, while also enabling multiplexed detection of

any number of products, side products

and contaminants.

MALDI-HTS is a label-free screening approach that accelerates assay development and provides opportunities for time course measurements from a single well.


Sergei Dikler Image edit


Author: SergeiDikler, PhD is  Technical Project Manager at Bruker Daltonics


Further Resources: 


MALDI High-Throughput Screening beyond 100,000 Samples per Day in Drug Discovery (Poster Note PN-05). Authors – Sergei Dikler and Paul J. Kowalski (both Bruker Daltonics Inc., Billerica, MA, USA)

Scott A. Busby and W. Adam G. Hill (both Novartis Institutes for BioMedical Research Inc., Cambridge, MA, USA)

Anja Resemann and Detlev Suckau (both Bruker Daltonik GmbH, Bremen, Germany)


Implementation of an Automated High Throughput MALDI Screening System for Drug Discovery. Authors – Scott Busby, Dominick Casalena and W. Adam Hill (Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, MA , USA)


Source: http://www.labnews.co.uk/


 


 



The need for speed

Montag, 23. Mai 2016

LABVOLUTION/BIOTECHNICA 2017: International Trade Fair for The Entire World of Lab Technology

Following its successful launch last year, the dual LABVOLUTION/BIOTECHNICA event is now preparing to underscore its reputation as a prime showcase for the entire world of lab technology. With a new spring timeslot, the next show – which covers everything from the life sciences to the chemical industry – will take place in Hall 2 of the Hannover Exhibition Center (Hannover, Germany) from 16 to 18 May 2017.


The focus will be on innovative products and services, Lab 4.0 and digitalization. Among the highlights at the upcoming event will be the next edition of the smartLAB display that made a big splash at last year’s LABVOLUTION. “LABVOLUTION/BIOTECHNICA presents the full spectrum of laboratory technology for users in every relevant sector,” said Dr. Jochen Köckler, Managing Board member at Deutsche Messe, adding: “This focus, along with exciting unique features such as the smartLAB display, transforms the event into a business platform for analytics, lab technology and biotechnology in northern Europe.” The trade fair’s main target groups are industry, research and science. With backgrounds in the chemical industry, food, environmental technology and the life sciences, trade visitors to Hannover will encounter the latest products and solutions for lab technology,


“LABVOLUTION/BIOTECHNICA presents the full spectrum of laboratory technology for users in every relevant sector,” said Dr. Jochen Köckler, Managing Board member at Deutsche Messe, adding: “This focus, along with exciting unique features such as the smartLAB display, transforms the event into a business platform for analytics, lab technology and biotechnology in northern Europe.” The trade fair’s main target groups are industry, research and science. With backgrounds in the chemical industry, food, environmental technology and the life sciences, trade visitors to Hannover will encounter the latest products and solutions for lab technology, automation and infrastructure and for analytics and specialist services. Featuring innovative products alongside best-practice examples, LABVOLUTION showcases the world of the laboratory along the entire value chain and across all applications. At the same time the event underlines its research strength at BIOTECHNICA. Science, R&D and companies from the biotech sector will be presenting the very latest advances and applications in fields such as personalized medicine, industrial biotechnology and diagnostics. Among the exhibitors addressing these topics will be universities, research institutes, biotech companies, and national and international pavilions. Special formats at LABVOLUTION/BIOTECHNICA 2017 will once again include a flanking conference on lab automation and the new LabUSER exhibitor forum. Located in the conference area of Hall 2, exhibitors at the LabUSER forum have the opportunity to present products and applications and also to offer training and courses. The special display “smartLAB – lab of the future” is unique throughout the tradeshow landscape and a major plus for LABVOLUTION. As well as being a showcase for the prototype lab, it features an accompanying forum and a conference program. The exchange of ideas and knowledge transfer in relevant biotechnology and life-science topics – such as Bio-IT, personalized medicine and


Special formats at LABVOLUTION/BIOTECHNICA 2017 will once again include a flanking conference on lab automation and the new LabUSER exhibitor forum. Located in the conference area of Hall 2, exhibitors at the LabUSER forum have the opportunity to present products and applications and also to offer training and courses. The special display “smartLAB – lab of the future” is unique throughout the tradeshow landscape and a major plus for LABVOLUTION. As well as being a showcase for the prototype lab, it features an accompanying forum and a conference program. The exchange of ideas and knowledge transfer in relevant biotechnology and life-science topics – such as Bio-IT, personalized medicine and bioeconomy – will take center stage at the BIOTECHNICA FORUM in 2017. Other topics to be featured next May will include careers & recruitment, partnering & networking, and support for start-ups. Last year saw the first parallel staging of LABVOLUTION and BIOTECHNICA. The story behind the two brands could hardly be more different, with the new LABVOLUTION presenting lab technology for all sectors and the visionary smartLAB, on the one hand, and the well-established BIOTECHNICA – a research and biotech event for Europe with a 30-year history – on the other hand. The two trade shows have now joined forces, benefiting exhibitors and visitors alike. Trade visitors across all sectors throughout northern Europe come to learn about current developments in lab technology and find out about the latest issues and innovations in biotechnology. At the same time, biotechnology users and researchers have the opportunity to view the entire spectrum of cutting-edge lab technology and infrastructure.


Source: Selectscience



LABVOLUTION/BIOTECHNICA 2017: International Trade Fair for The Entire World of Lab Technology

Donnerstag, 12. Mai 2016

When do Drug Patents Expire and When can Generics Launch?

Drug patents play a central role in the pharmaceutical industry. Fortunes change change overnight as innovators lose patent protection, and as generics start to gain market share.

A challenge in navigating this exciting space is that it can be difficult to determine when drug patents expire, and when generics can launch. Differences in international patent laws and in regulatory processes can impact generic entry. Furthermore, some patents may block all generic entry, whereas others may only block certain applications.

This slideshow sheds light on drug patent expiration and generic launch. It describes the various kinds of patents, and how to determine the extent to which a patent may block generic entry. It also illustrates the various kinds of regulatory protections and how they coordinate  with patents to impact generic launch.

 



 When do drug patents expire?

When do Drug Patents Expire and When can Generics Launch?

Analytica Munic 2016 ongoing

[vc_row][vc_column][vc_column_text]analytica is the International Trade Fair for Laboratory Technology, Analysis and Biotechnology. Its unique exhibition profile unites all topics that pertain to modern analysis in research and industry. The various exhibition sectors will give you a comprehensive overview of the market. Be sure to also visit the scientific analytica conference and our practice-oriented program of related events.


[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”23062″ img_size=”full”][/vc_column][/vc_row][vc_row][vc_column][vc_custom_heading text=”10-13 May 2016″ font_container=”tag:h2|font_size:50|text_align:left” use_theme_fonts=”yes”][/vc_column][/vc_row]



Analytica Munic 2016 ongoing

Sonntag, 1. Mai 2016

ZipDose® - How APRECIA PHARMACEUTICALS sees the future of high-dose medication

In 2015 Aprecia got their first 3D printed drug product approved by the FDA. The technology used to print an oral dose drug is called Powder-liquid three-dimensional printing (3DP) and was already developped in the late 1980’s at the Massachusetts Institute of Technology (MIT). The principle is simple: An aqueous fluid binds together multiple layers of powder in a layer-by-layer process. This new technology promises to enable delivery of high-dose medications in a rapidly disintegrating form.

[vc_row][vc_column][vc_column_text]

Is this the future of drug manufacturing?



[/vc_column_text][/vc_column][/vc_row]

ZipDose® - How APRECIA PHARMACEUTICALS sees the future of high-dose medication

Samstag, 23. April 2016

Screw Cap Tube Recapper Accelerates Sample Storage Process


The new Micronic Univo Screw Cap Recapper SR096 offers users the ability to cap, decap or recap 96 tubes with Screw Caps in a single action.


Easy to install and operate, the Univo SR096 decaps Screw Caps from a full 96-tube storage rack in less than 30 seconds. Through the graphical touch screen interface, the operator is able to select any rack to cap, decap or recap without using different adapters for different tube sizes. The Screw Cap Recapper uses a precisely determined toque value for optimal sealing quality thereby minimizing sample evaporation and maximizing the integrity of your valuable samples.


Compatible with Micronic Screw Caps and Screw Cap tubes, as well as caps from other brands, the Univo SR096 provides a versatile solution for many various sample storage processes.


Designed to improve your productivity the Micronic Screw Cap Recapper can be used as a stand-alone instrument or be simply integrated into a fully automated laboratory environment. The optional sensor verifies that all caps have been removed, allowing effective use in automation process, and minimizes potential cross-contamination. In addition, the Ethernet connection gives many possibilities for different communication protocols. Each extremely reliable and robust Micronic Screw Cap Recapper comes with technical support and a 3-Year warranty.


For more information, visit http://www.micronic.com/product/univo-screw-cap-recapper-sr096.



SOURCE: Micronic Europe BV



Screw Cap Tube Recapper Accelerates Sample Storage Process

Sonntag, 17. April 2016

Porvair Sciences to launch new microplate for genomics at Analytica 2016

Porvair Sciences has announced that it will launch an exciting new microplate for genomics sample preparation at the forthcoming Analytica 2016 exhibition in Munich, Germany.


Designed with thickened walls and strengthened ribs underneath to stop cracking or leaking when used in Geno/Grinder or Tissulyser machines the robust 96-well 2ml deep well Genomics Sample Preparation Plate sets a new standard for high throughput genomics sample preparation.


image


Unlike most commercially available deep well plates, the Genomics Sample Preparation Plate has been proven to withstand demanding applications using steel ball bearings in the wells shaken at up to 1500rpm used to homogenise seeds, leaves or tissue ready for DNA extraction.


Manufactured from superior grade, ultra-clean polypropylene samples the new Genomics Sample Preparation Plate has been tested at the National Centre for Mass Spectroscopy Excellence at Swansea University (UK) and has been found to be free of measurable leachates / extractables as determined on their most sensitive time-of-flight MS instruments. Genomics Sample Preparation Plates are sold individually or as part of a package including matching silicone impact support mat and EVA cap mat.


Also at Analytica 2016, Porvair Sciences will show its latest products that enable Lab Automation facilities to optimise sample preparation and improve productivity.  These include the Ultravap Mistral – a product designed to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from microplates, the Universal Robotic Manifold for productive automation of SPE or DNA clean-up procedures and the MiniSeal Plus electronically controlled thermal sealer developed for laboratories sealing small to medium batches of microplates.


At this important meeting – Porvair Sciences will also be showing a selection of its comprehensive range of applications optimised microplates.


For further information please visit Analytica Hall A1, Stand 514 or contact Porvair Sciences on +44-1978-666222 or int.sales@porvair-sciences.com



Porvair Sciences to launch new microplate for genomics at Analytica 2016

Dienstag, 12. April 2016

New laboratory automation system opens

DOHA: A new Laboratory Automation System was officially opened by Minister of Public Health H E Dr Hanan Mohamed Al Kuwari in Hamad General Hospital (HGH) yesterday.


The system handles and analyses a large volume of specimens and can accommodate up to 96,000 tests a day.


The computerised control system allows more functionality such as quality control monitoring, auto verification of results and the ability to collect data for further improvements.


“The new system will improve efficiencies, reduce turnaround time for tests to be returned and, more importantly, ensure high quality patient safety is maintained, thanks to the automation process,” said Dr Al Kuwari.


“This is another example that shows HMC’s commitment to improve the care patients receive by developing excellence in healthcare in Qatar through high quality and an efficiency of service, something that was recently recognised when HMC became the first healthcare system across the globe to have all of its hospitals accredited by Joint Commission International (JCI) under the Academic Medical Centre programme,” she added.


The new system, in place since September 2015, also allows add-on orders to be completed electronically without human intervention and includes a compartment with a capacity of 15,000 tubes for storing varied specimens.


This extra capacity is proving very useful when coping with the high number of blood test requests received from all over the country.


“As the population grows, we are receiving more and more requests for tests and this type of analyser allows us to perform up to 110 types.


“The new system ensures we provide a very efficient service for our patients and our external partners such as Army clinic, Police clinic, Medical Commission, Qatar Petroleum, Aspetar Hospital, Primary Health Care Centre and private hospitals.


“This also means we can reduce the time it takes for tests to be competed from 24 hours to an average of three for routine orders,” said Dr Ajayab Al Nabet, Chairperson,  Department of Laboratory, Medicine and Pathology, HGH.The Peninsula



New laboratory automation system opens

Mittwoch, 6. April 2016

Compliance in Lab Automation

I have searched the internet for “compliance in lab automation”, and believe it or not, there is not a single website with collected resources. Since there are some must-read documents, already uploaded to the site, I will link them together in this post. The implementation of this documents in everyday processes of certified laboratories is the only way to reach an environment of trust and to succeed in business. Some principles are difficult to accomplish but it`s definitely the best investment when it comes to future stability of a company. If there is something to link in addition about compliance in automated laboratories, please feel free to contribute in the comments secrion


THE APPLICATION OF THE PRINCIPLES OF GLP TO COMPUTERISED SYSTEMS


OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING


WHO Handbook (GOOD LABORATORY PRACTICE IN GLP)


AGIT (GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS)


AGIT (Guidelines for the archiving of electronic raw data)


CFR Part 11


 



Compliance in Lab Automation

Freitag, 1. April 2016

Amping antimicrobial discovery with automation

The antimicrobial arsenal that we count on to save millions of lives each year is alarmingly thin—and these microbes are rapidly evolving resistance to our weapons. But help may be on the way: In a study posted in the AMB Express, researchers from the National Institute of Standards and Technology (NIST) show that automated techniques commonly used to screen new drugs for mammalian cell toxicity could also dramatically speed up the challenging task of antimicrobial discovery.


 

ampingantimi

A robotic device designed for high-throughput screening of drug toxicity also could also accelerate antimicrobial discovery, NIST researchers report. Credit: Stoughton/NIST


In the age-old struggle between humans and microbes, bacteria seem to be regaining the offensive. Only around a dozen classes of chemicals protect us from the myriad pathogens that populate our environment. Numerous agencies, including the World Health Organization and the Centers for Disease Control and Prevention, have recently warned that evolved resistance could soon render common antibiotics useless, and that few replacement drugs are in the pipeline.


The shortage of new antimicrobials is not a result of scientists lacking candidate chemicals. The fungal and plant worlds abound with potential antimicrobials, and chemists concoct new synthetic molecules all the time. However, a major bottleneck occurs at the lab bench. Any candidate compound must be tested at multiple concentrations against multiple strains of bacteria in different forms. This remains a cumbersome process, with numerous time- and labor-intensive steps that lab workers must currently carry out by hand.


But NIST researcher Samuel Forry and colleagues are convinced that the process could be vastly sped up using automation. To do so, Forry and his team looked to one of the pharmaceutical industry’s most powerful tools: high-throughput screening. For several decades, companies have routinely used automated systems to test potential drugs’ effects on mammalian cells in culture. In these studies, robots prepare samples of cells in arrays of small plastic wells, inject measured amounts of drugs and test whether cells live or die. The method can quickly assess multiple chemicals at different concentrations, all in parallel and with minimal human intervention.


High-throughput screening has seen limited use for antimicrobial discovery, Forry says, because less research and development money is available and because of the large variation among microbial populations and growth conditions. Hoping to stimulate the field, Forry and his team adapted a high-throughput screening robot for antimicrobial testing. The researchers tested a set of antimicrobial compounds known as pyridinium salts against the common bacterium Streptococcus mutans, which causes tooth decay.


Part of the challenge in identifying useful antimicrobial compounds is that chemicals that kill free-swimming cells are often less effective against the same bacteria growing in biofilms like the plaque that can form on teeth. So Forry’s team used automation to culture both free-swimming cells and biofilms, as well as an intermediate state, side-by-side in 96-well plates. The researchers measured antimicrobial activity in three different ways by identifying the concentrations that reduced bacterial activity by half, that prevented any detectable activity, and that entirely killed the bacteria. They determined the drugs’ effects with high throughput by measuring light passing through the wells or using chemicals that change color to indicate metabolic activity.


The team found that the automated system delivered results indistinguishable from those obtained by doing the experiments by hand. More importantly, the robot took only a third as much time as humans do, freed up laboratory personnel for other tasks, and carried out the procedures without errors. “That’s a huge improvement from the point of view of laboratory workflow and a great boon for people trying to identify and characterize antimicrobials,” Forry says.


The trials weren’t fully automated—for instance, the researchers moved samples from the incubator to the screening robot by hand—but Forry says his team has demonstrated the concept, and existing technology can fill in the remaining steps. He expects other research labs will adopt the technology first, followed by pharmaceutical companies. “Once a number of people start to use this and find that it works for them as well as it has worked for us, I could easily see companies and contract labs doing it.”


Read more at: http://phys.org/


Provided by: National Institute of Standards and Technology



Amping antimicrobial discovery with automation